(98 days)
Not Found
No
The summary describes a mechanical fluid administration device and does not mention any computational or data-driven features indicative of AI/ML.
No.
The device facilitates the administration of drugs and solutions and the withdrawal of fluids, but it does not directly treat or diagnose a disease or condition. Its primary function is to provide needleless access to a vascular system.
No
The device is described as an injection site used for fluid administration or withdrawal, and for eliminating needle-stick injuries. While it can be used to sample blood, its primary function is not to diagnose conditions, but rather to facilitate fluid management and drug delivery.
No
The device description clearly outlines a physical, disposable medical device (Luer Activated Device and Extension Sets) intended for fluid administration and withdrawal, not a software application.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the administration and withdrawal of fluids (drugs, solutions, blood) to and from a patient's vascular access device. This is a direct interaction with the patient's circulatory system for therapeutic or diagnostic purposes (fluid withdrawal), not for testing samples in vitro (outside the body).
- Device Description: The description focuses on the mechanical function of the device for fluid management and access to the vascular path. It doesn't mention any components or processes related to analyzing biological samples for diagnostic information.
- Lack of IVD Characteristics: There is no mention of reagents, assays, sample analysis, or generating diagnostic results, which are hallmarks of IVD devices.
The device is a medical device used for patient care, specifically for vascular access and fluid management, but it does not perform in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
The Baxter Neutral Luer Activated Device is intended for single patient use with a vascular access device for the administration of drugs and solutions without needles, thus eliminating the potential for needle-stick injuries during use. This device is an in-line injection site which can be connected to standard male Luer adapters (e.g., syringes or sets) for the continuous or intermittent fluid administration or the withdrawal of fluids. This device may be used with low pressure power injectors having a maximum pressure of 325 psi (2241 kPa) and a maximum flow rate of 10 mL/s.
Product codes
FPA
Device Description
The Neutral Luer Activated Device (LAD) and Extension Sets with Neutral Luer Activated Device are single use disposable devices intended for use with a vascular access device for continuous or intermittent fluid administration or withdrawal of fluids. The device is an in-line access site and can be connected to male Luer adapters (e.g., syringes or sets) to allow needleless access to the fluid or vascular path and is designed to be easy to swab.
A saline flush of 10 mL is able to clear the Neutral LAD of blood after sampling blood through the device. The Neutral LAD is clear and allows the clinician to view the fluid path of the device.
The Neutral LAD has a low priming volume (0.08 mL) that allows medication to be flushed from the device with small amounts of fluid and is the maximum amount of medication that could potentially remain in the device when administered to a patient prior to flushing. A LAD with a low priming/residual volume is favored for pediatric patients or patients requiring fluid restriction.
The device is a neutral fluid displacement LAD and does not require a specific clamping sequence in order to be used safely. This neutral displacement design has the added benefit of helping to reduce the occurrence of thrombotic catheter occlusions by limiting the reflux of blood into the catheter.
The Neutral LAD may be used with low pressure power injectors having a maximum pressure of 325 psi (2241 kPa) and a maximum flow rate of 10 mL/s.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
pediatric patients or patients requiring fluid restriction
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Baxter Healthcare Corporation conducts risk analyses and design verification tests based on the result of these analyses. This device met all the acceptance criteria for all functional, biocompatibility, microbial ingress, sterility and ease of use requirements and the data support that the device is appropriately designed for its intended use. Testing supports use of the device for 7 days and/or 200 actuations.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
Traditional 510(k) Premarket Notification Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated Device Section 5, 510(k) Summary
MAY 2 2 2012
5. 510(k) SUMMARY
February 13, 2012
OWNER:
Baxter Healthcare Corporation One Baxter Parkway Deerfield, Illinois 60015
CONTACT PERSON:
Nanette Hedden Sr. Manager, Global Regulatory Affairs 1620 Waukegan Road McGaw Park, Illinois 60085 Telephone: (847) 270-4871 Fax: (847) 270-4900 Email: Nanette_hedden@baxter.com
DEVICE NAME:
Trade name: Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated Device
| Code | Product |
|---|---|
| 7N8399 | Neutral Luer Activated Device ,Power Injectable (325 psi, 2241 kPa), |
| 7N8371 | Neutral Luer Activated Device Non-DEHP Y-Type Microbore Catheter |
| Extension Set | |
| 7N8377 | Neutral Luer Activated Device Non-DEHP Y-Type Standard Bore |
| Catheter Extension Set | |
| 7N8378 | Neutral Luer Activated Device Non-DEHP Standard Bore Catheter |
| Extension Set | |
| 7N8300 | Neutral Luer Activated Device Non-DEHP Microbore Catheter |
| Extension Set, Power Injectable (325 psi, 2241 kPa), |
1
Common name: IV Administration Set
Classification name: IV Administration Set (21 CFR 880.5440, Product Code FPA)
PREDICATE DEVICE:
Three predicate devices are cited in support of the substantial equivalence determination:
- · Baxter Healthcare Solution Administration Sets with Capped Luer Activated Valve. K003225 cleared on October 19, 2000
- · Pressure Rated Extension Sets, K083472 cleared on November 18, 2008
- · InVision Plus Injection Port Systems, K991653, cleared June 24, 1999
DESCRIPTION OF THE DEVICE:
The Neutral Luer Activated Device (LAD) and Extension Sets with Neutral Luer Activated Device are single use disposable devices intended for use with a vascular access device for continuous or intermittent fluid administration or withdrawal of fluids. The device is an in-line access site and can be connected to male Luer adapters (e.g., syringes or sets) to allow needleless access to the fluid or vascular path and is designed to be easy to swab.
A saline flush of 10 mL is able to clear the Neutral LAD of blood after sampling blood through the device. The Neutral LAD is clear and allows the clinician to view the fluid path of the device.
The Neutral LAD has a low priming volume (0.08 mL) that allows medication to be flushed from the device with small amounts of fluid and is the maximum amount of medication that could potentially remain in the device when administered to a patient prior to flushing. A LAD with a low priming/residual volume is favored for pediatric patients or patients requiring fluid restriction.
The device is a neutral fluid displacement LAD and does not require a specific clamping sequence in order to be used safely. This neutral displacement design has the added benefit of helping to reduce the occurrence of thrombotic catheter occlusions by limiting the reflux of blood into the catheter. 1.2
1 Hadaway, Lynn C., "Reopen the Pipeline for IV Therapy," Nursing2005, Volume 33, Number 8, 54-62.
2 Infusion Nursing: An Evidence-Based Approach, ed. Mary Alexander, et al., (St. Louis: Saunders Elsevier, Inc. 2010), 495-515.
2
The Neutral LAD may be used with low pressure power injectors having a maximum pressure of 325 psi (2241 kPa) and a maximum flow rate of 10 mL/s.
STATEMENT OF INTENDED USE:
The Baxter Neutral Luer Activated Device is intended for single patient use with a vascular access device for the administration of drugs and solutions without needles, thus eliminating the potential for needle-stick injuries during use. This device is an in-line injection site which can be connected to standard male Luer adapters (e.g., syringes or sets) for the continuous or intermittent fluid administration or the withdrawal of fluids. This device may be used with low pressure power injectors having a maximum pressure of 325 psi (2241 kPa) and a maximum flow rate of 10 mL/s.
TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE:
The Neutral Luer Activated Device and Extension sets with the Neutral Luer Activated Device are substantially equivalent to the predicate devices listed above. The Neutral LAD is a neutral fluid displacement device that does not require a specific clamping technique to work safely and effectively for continuous or intermittent fluid delivery. The Neutral LAD is designed to be easy to swab and is appropriate for use with power injectors having a maximum pressure of 325 psi (2241 kPa) and a maximum flow rate of 10 mL/s. The product is sterile and non-pyrogenic. Testing supports use of the device for 7 days and/or 200 actuations.
DISCUSSION OF NONCLINICAL TESTS:
Baxter Healthcare Corporation conducts risk analyses and design verification tests based on the result of these analyses. This device met all the acceptance criteria for all functional, biocompatibility, microbial ingress, sterility and ease of use requirements and the data support that the device is appropriately designed for its intended use.
CONCLUSION:
The Neutral Luer Activated Device (LAD) and Extension Sets with the Neutral Luer Activated Device are substantially equivalent to the predicate devices.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
MAY 2 2 2012
Ms. Nanette Hedden Associate Director, Global Regulatory Affairs Baxter Healthcare Corporation 1620 Waukegan Road McGaw Park, Illinois 60085
Re: K120443
Trade/Device Name: Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated Device
Regulation Number: 21 CFR 880.5440
Regulation Name: Set, Administration, Intravenous Regulatory Class: II
Product Code: FPA
Dated: April 27, 2012
Received: May 1, 2012
Dear Ms. Hedden:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Hedden
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Anthony D. arut
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE
510(k) Number (if known):
Device Name: Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated Device
Indications for Use:
The Baxter Neutral Luer Activated Device is intended for single patient use with a vascular access device for the administration of drugs and solutions without needles, thus eliminating the potential for needle-stick injuries during use. This device is an in-line injection site which can be connected to standard male Luer adapters (e.g., syringes or sets) for the continuous or intermittent fluid administration or the withdrawal of fluids. This device may be used with low pressure power injectors having a maximum pressure of 325 psi (2241 kPa) and a maximum flow rate of 10 mL/s.
Prescription Use X
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Rhl C. Ogen 5/22/12
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number:
-04/43